Human Insulin Market worth 39.13 Billion USD by 2020

1
MarketsandMarkets Presents
Human Insulin Market worth 42 Billion by 2020
2

• The Human Insulin Market by Product Type Human
  Insulin (Short Acting, Intermediate Acting,
  Premixed), Modern Human Insulin (Rapid Acting,
  Long Acting, Premixed), by Brand (Lantus,
  Apidra, Levemir, NovoRapid, Novomix, Tresiba,
  Others) - Forecast to 2020provides a detailed
  overview of the major drivers,restraints,
  challenges, opportunities, current market
  trends,and strategies impacting the global human
  insulin market along with the estimates and
  forecasts of the revenue and share analysis.
• Browse 110 market data tables and 55 figures
  spread through 232 pages and in-depth TOC on
  "Human Insulin Market by Product Type Human
  Insulin (Short Acting, Intermediate Acting,
  Premixed), Modern Human Insulin (Rapid Acting,
  Long Acting, Premixed), by Brand (Lantus,
  Apidra, Levemir, NovoRapid, Novomix, Tresiba,
  Others) - Forecast to 2020"
• http//www.marketsandmarkets.com/Market-Reports/hu
  man-insulin-market-229295783.html

3

Early buyers will receive 10 customization on
Reports.
4

• The global human insulin market crossed 23
  billion in 2013 and is poised to grow at a high
  double-digit CAGR from 2015 to 2020.
• The market is segmented based on products, and
  types of insulin. Based on products, the global
  human insulin market is segmented into biologics
  and biobetters, and biosimilars/biogenerics.
  Human insulin market is also segmented into
  traditional and modern human insulin. Of these,
  modern human insulin and biosimilarswill be the
  fastest-growing market in the next five years.The
  major factors propelling this growth are cost
  effective treatment offered while using modern
  human insulin and low price of biosimilars/biogene
  ric drugs of human insulin thereby stimulating
  the demand for biosimilar human insulin products.
  
• By type of insulin, traditional human insulin is
  further segmented into short acting human
  insulin, intermediate acting human insulin, and
  premixed whereas Modern human insulin is
  fragmented into long acting human insulin, rapid
  acting human insulin, and premixed modern human
  insulin. Of all, long acting human insulin
  accounted for the largest share and pre-mixed
  human insulin will be the fastest growing market
  witnessing double-digit growth between 2015-2020.

5

• Geographic analysis reveals that North America is
  the largest contributor to the global human
  insulin market in 2015 and will witness moderate
  growth between 2015-2020.
• Asia-Pacific will be the fastest growing market
  for human insulin production, development, and
  distribution. Further, Asia-Pacific countries are
  considered to be the lucrative ones for investors
  to invest in for manufacturing and clinical
  activities of pipeline and existing human insulin
  product. Major players enter the Asian market
  with the purpose to collaborate with various CMO
  and CRO existing in this region that fosters the
  development of human insulin at lower cost
  compared to the other region across the globe.
  The demand for human insulin will be on the rise
  in coming five years due to the high prevalence
  rate of diabetes as well as low price of human
  insulin.
• The key players in the market are Novo Nordisk
  (Denmark), Eli Lilly (U.S),SanofiAventis(France),B
  iocon (India), Julphar(U.A.E),Wockhardt
  (India),SemBioSys (Canada), and GSK (U.K.).

6
About MarketsandMarkets
Markets and Markets is a global market research
and consulting company based in the U.S. We
publish strategically analyzed market research
reports and serve as a business intelligence
partner to Fortune 500 companies across the
world. Markets and Markets also provides
multi-client reports, company profiles,
databases, and custom research services. They
cover thirteen industry verticals, including
advanced materials, automotive and
transportation, banking and financial services,
biotechnology, chemicals, consumer goods, energy
and power, food and beverages, industrial
automation, medical devices, pharmaceuticals,
semiconductor and electronics, and
telecommunications and IT. We at Markets and
Markets are inspired to help our clients grow by
providing apt business insight with our huge
market intelligence repository.
7
Contact Us
Mr. RohanMarkets and Markets UNIT no 802, Tower
no. 7, SEZ Magarpatta city, Hadapsar Pune,
Maharashtra 411013, India 1-888-600-6441 Email
sales_at_marketsandmarkets.com Visit
MarketsandMarkets Blog _at_ http//mnmblog.org/market
-research/healthcare/medical-devices Connect
with us on LinkedIn _at_ http//www.linkedin.com/comp
any/marketsandmarkets